{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T21:12:12Z","timestamp":1793740332931,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106335","type":"journal-article","created":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T21:27:39Z","timestamp":1781731659000},"page":"106335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label study"],"prefix":"10.1016","volume":"129","author":[{"given":"Han","family":"Phan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Barthel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Molly","family":"Madden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A.","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abby","family":"Bronson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Thaler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole Rempel","family":"Kilburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Amato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"MacDougall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2026.106335_bib1","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2021.647010","article-title":"Abnormal calcium handling in Duchenne muscular dystrophy: mechanisms and potential therapies","volume":"12","author":"Mareedu","year":"2021","journal-title":"Front Physiol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106335_bib2","doi-asserted-by":"crossref","first-page":"3710","DOI":"10.1073\/pnas.90.8.3710","article-title":"Dystrophin protects the sarcolemma from stresses developed during muscle contraction","volume":"90","author":"Petrof","year":"1993","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106335_bib3","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1152\/ajpendo.00095.2015","article-title":"Effects of aging, exercise, and disease on force transfer in skeletal muscle","volume":"309","author":"Hughes","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/j.ebiom.2026.106335_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3389\/fnagi.2014.00188","article-title":"Skeletal muscle homeostasis in Duchenne muscular dystrophy: Modulating autophagy as a promising therapeutic strategy","volume":"6","author":"De Palma","year":"2014","journal-title":"Front Aging Neurosci"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106335_bib5","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.3390\/biomedicines9101366","article-title":"Inflammation in Duchenne muscular dystrophy\u2013exploring the role of neutrophils in muscle damage and regeneration","volume":"9","author":"Tulangekar","year":"2021","journal-title":"Biomedicines"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106335_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1085\/jgp.201010436","article-title":"Mechanisms of muscle weakness in muscular dystrophy","volume":"136","author":"Goldstein","year":"2010","journal-title":"J Gen Physiol"},{"issue":"1\u20132","key":"10.1016\/j.ebiom.2026.106335_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1023\/A:1006812004945","article-title":"The molecular basis of activity-induced muscle injury in Duchenne muscular dystrophy","volume":"179","author":"Petrof","year":"1998","journal-title":"Mol Cell Biochem"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106335_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1007\/BF00858725","article-title":"The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history","volume":"240","author":"Bushby","year":"1993","journal-title":"J Neurol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106335_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00858726","article-title":"The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. II. Correlation of phenotype with genetic and protein abnormalities","volume":"240","author":"Bushby","year":"1993","journal-title":"J Neurol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106335_bib10","doi-asserted-by":"crossref","first-page":"4763","DOI":"10.1007\/s00415-023-11837-5","article-title":"Diagnosis and management of Becker muscular dystrophy: the French guidelines","volume":"270","author":"Magot","year":"2023","journal-title":"J Neurol"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106335_bib11","doi-asserted-by":"crossref","first-page":"2360","DOI":"10.1002\/acn3.51925","article-title":"Natural history of Becker muscular dystrophy: a multicenter study of 225 patients","volume":"10","author":"Nakamura","year":"2023","journal-title":"Ann Clin Transl Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106335_bib12","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s00415-025-13126-9","article-title":"Characterisation of a large, single-centre cohort of patients with Becker muscular dystrophy to inform standardised care guidelines","volume":"272","author":"Riguzzi","year":"2025","journal-title":"J Neurol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106335_bib13","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.nmd.2009.06.368","article-title":"Reliability of the North Star Ambulatory Assessment in a multicentric setting","volume":"19","author":"Mazzone","year":"2009","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.ebiom.2026.106335_bib14","doi-asserted-by":"crossref","DOI":"10.1038\/srep32439","article-title":"Functional changes in Becker muscular dystrophy: implications for clinical trials in dystrophinopathies","volume":"6","author":"Bello","year":"2016","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106335_bib15","doi-asserted-by":"crossref","first-page":"e513","DOI":"10.1212\/WNL.0000000000012233","article-title":"Selection approach to identify the optimal biomarker using quantitative muscle MRI and functional assessments in Becker muscular dystrophy","volume":"97","author":"van de Velde","year":"2021","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2026.106335_bib16","article-title":"Lessons for future clinical trials in adults with Becker muscular dystrophy: disease progression detected by muscle magnetic resonance imaging, clinical and patient-reported outcome measures","volume":"31","author":"De Wel","year":"2024","journal-title":"Eur J Neurol"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106335_bib17","doi-asserted-by":"crossref","DOI":"10.1212\/NXG.0000000000200285","article-title":"Longitudinal changes of motor function in Becker muscular dystrophy","volume":"11","author":"Bello","year":"2025","journal-title":"Neurol Genet"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106335_bib18","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000214071","article-title":"Sensitivity of different clinical outcome measures in assessing adults with Becker muscular dystrophy: a 3-year natural history study","volume":"105","author":"Schrama","year":"2025","journal-title":"Neurology"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106335_bib19","doi-asserted-by":"crossref","DOI":"10.1172\/JCI153837","article-title":"Modulating fast skeletal muscle contraction protects skeletal muscle in animal models of Duchenne muscular dystrophy","volume":"133","author":"Russell","year":"2023","journal-title":"J Clin Invest"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106335_bib20","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1002\/mus.28444","article-title":"A Phase 1, double-blind, placebo-controlled trial of sevasemten (EDG-5506), a selective modulator of fast skeletal muscle contraction, in healthy volunteers and adults with Becker muscular dystrophy","volume":"72","author":"Donovan","year":"2025","journal-title":"Muscle Nerve"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106335_bib21","doi-asserted-by":"crossref","DOI":"10.1093\/ptj\/pzac113","article-title":"Validation of the North Star Assessment for limb-girdle type muscular dystrophies","volume":"102","author":"James","year":"2022","journal-title":"Phys Ther"},{"issue":"17","key":"10.1016\/j.ebiom.2026.106335_bib22","doi-asserted-by":"crossref","first-page":"9293","DOI":"10.3390\/ijerph18179293","article-title":"Absolute reliability and concurrent validity of hand-held dynamometry in shoulder rotator strength assessment: systematic review and meta-analysis","volume":"18","author":"Chamorro","year":"2021","journal-title":"Int J Environ Res Public Health"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106335_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1002\/mus.27222","article-title":"Elevation of fast but not slow troponin I in the circulation of patients with Becker and Duchenne muscular dystrophy","volume":"64","author":"Barthel","year":"2021","journal-title":"Muscle Nerve"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106335_bib24","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/acn3.70035","article-title":"Universal proteomic signature after exercise-induced muscle injury in muscular dystrophies","volume":"12","author":"Stemmerik","year":"2025","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106335_bib25","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3233\/JND-140066","article-title":"Muscle-derived proteins as serum biomarkers for monitoring disease progression in three forms of muscular dystrophy","volume":"2","author":"Burch","year":"2015","journal-title":"J Neuromuscul Dis"},{"issue":"8748","key":"10.1016\/j.ebiom.2026.106335_bib26","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/0140-6736(91)92671-N","article-title":"Prevalence and incidence of Becker muscular dystrophy","volume":"337","author":"Bushby","year":"1991","journal-title":"Lancet"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002185?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002185?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:04:56Z","timestamp":1785891896000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002185"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":26,"alternative-id":["S2352396426002185"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106335","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of sevasemten (EDG-5506) on safety, biomarkers, and functional measures in adults with Becker muscular dystrophy: results of a phase 1b, open-label study","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106335"}}